SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Late Breaking Data Presented at the American Diabetes Association 71st Annual Scientific Sessions Evaluate the Safety and Tolerability of TAK-875, Takeda Pharmaceutical Co. Ltd.'s Investigational Compound for the Treatment of Type 2 Diabetes